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ml), possible injury (CIIS 10-15, 0.3170.132 ng/ml), probable injury
(CIIS >15, 0.3760.132 ng/ml) group. MMP-9 levels were signiﬁcantly
higher in the probable injury (CIIS >15) patients compared to the
possible injury (CIIS 10-15) patients (p < 0.001).
CONCLUSIONS An increase in serum MMP-9 enzyme levels is a risk
factor of the coronary atherosclerotic plaque rupture (OR¼0.001,
p<0.001).GW26-e3856
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OBJECTIVES Acute myocardial infarction (AMI) is a critical global
health problem. Therefore, new medicines and advanced treatments
with less side-effect or complication are needed. Previous studies
suggested that Danhong injection (DHI) might be an effective medi-
cine in AMI treatment. However, its efﬁcacy and safety have not yet
been systematically evaluated. So we aimed to systematically assess
the efﬁcacy and safety of DHI for AMI patients.
METHODS We searched several electrical databases and hand-
searched several Chinese medical journals. Randomized controlled
trials (RCTs) comparing DHI plus conventional western medicine with
conventional western medicine plus placebo and RCTs comparing DHI
plus conventional western medicine with conventional western
medicine were retrieved. Study screening, data extraction, quality
assessment and data analysis were conducted in accordance with the
Cochrane standards.
RESULTS 13 RCTs enrolling 979 patients were included. Danhong in-
jection could signiﬁcantly reduce the risk of mortality, recurrent
angina, arrhythmia, and heart failure. In addition, Danhong injection
was associated with improvement of left ventricular ejection fraction
(LVEF) and reperfusion. However, the safety of DHI remained un-
known for limited data.
CONCLUSIONS Danhong injection might be a potentially efﬁcacious
treatment for AMI patients. Nevertheless, the safety of Danhong in-
jection remained uncertain for limited information. Due to the overall
quality of all included studies is generally low, more high quality RCTs
are expected to validate the efﬁcacy and safety of DHI for AMI
patients.GW26-e5333
Comparison Long-term Outcomes of Conservative vs PCI Treatment in
NSTE-ACS Patients with Intermediate Coronary Stenosis
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PLA General Hospital
OBJECTIVES (1) To evaluate the clinical outcomes of patients with
intermediate coronary lesions, comparing those who underwent PCI
for the intermediate lesion to those who did not (MT);
(2) to determine the predictive factors of major adverse clinical
cardiac events (MACE) in follow-ups.
METHODS A total of 222 patients (mean age 6310 years), with non-ST
segment elevation acute coronary syndrome (UA/NSTMI) who had at
last one intermediate coronary lesions (diameter stenosis rate 40-
70%) were included in the study. PCI of an intermediate lesion was
underwent in a group of 110 patients (PCI group). And the other 112
patients were treated with medical treatment by guideline (MT
group). In all patients serious coronary lesions (diameter stenosis
rate 70%) were treated with PCI. MACE (cardiac death, nonfatal
myocardial infarction, a need for target lesion revascularization) and
the presence of angina were evaluated in follow-ups.
RESULTS There was no difference regarding the mean percent
diameter stenosis (54.79.3% and 54.66.8%, P <0.01) between the
two groups. The clinical features between two groups are similar.
Although With the similar secondary prevention of coronary heart
disease, quiting smoking, regular exercise, having clopidogrel andstatins using, and dyslipidemia controlling were higher in the PCI
group compared with MT group (P <0.05). At a mean follow - up of
3011 months, the tolal occurrence of MACE and presence of angina
were similar between groups. PCI group with moderate TIMI risk has
more incidence of TLR than MT group. TIMI risk score is a predictive
factor of MACE (hazard ratio 1.38, 95% CI 1.057–1.800, P < 0.05).
CONCLUSIONS (1) In patients with UA/NSTMI, PCI for intermediate
coronary lesions did not reduce the occurrence of angina and MACE,
especially in those with moderate TIMI risk.
(2) TIMI score is a very powerful predictive factor for long prognosis
in UA/NSTMI patients.
(3) The secondary prevention of coronary heart disease and medical
treatments should be emphasized.GW26-e1376
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OBJECTIVES To observe the change of plasma BNP level, and the
relationship between it and reconstruction and prognosis in patients
with acute myocardial infarction undergoing early intervention
treatment.
METHODS Choose 114 cases of hospitalized patients with initial AMI,
all underwent emergency percutaneous coronary intervention (PCI),
infarction related artery (IRA) opened in 69 cases (opened group), did
not open in 43 cases (not opened group). On admission to detect
myocardial injury markers [CK, CK - MB, troponin I (cTnI)], to mea-
sure left ventricular ejection fraction (LVEF), left ventricular end-
diastolic volume index (LVEDVI) on the seventh day of admission by
using ultrasound. TO measure the level of BNP in plasma on admis-
sion, 24 h after AMI, the seventh day of admission (marked them as
BNP1 BNP2 BNP3 respectively); Postoperative follow-up of 2 years,
recording the occurrence of major adverse cardiovascular events
(MACE).
RESULTS Comparing serum level of CK, CK - MB, cTnI, TG, LDL - C in
two groups on admission, they all have no signiﬁcant differences (P
> 0.05);7 days after admission, comparing opened group with not
opened group, the level of LVEF increased signiﬁcantly, but LVEDVI
reduced (The former P < 0.05, the latter P > 0.05); BNP1 has no
statistical signiﬁcant differences between the two groups, BNP2
increased signiﬁcantly more than BNP1, BNP3 (P < 0.05), the level of
BNP2, BNP3 increased signiﬁcantly in opened group than not opened
group(P < 0.05). Three time points detection of BNP level and
LVEDVI and CK, CK - MB, cTnI there were positive correlation (P <
0.01). LVEF is negatively related (P < 0.01). the occurrence of MACE
in opened group have 10 cases(14.5%), not opened group have 16
cases(37.2%),(P<0.05); BNP2 predicted MACE within 2 years (cardiac
death, new or worsening heart failure, nonfatal myocardial infarc-
tion) in the area under the ROC curve was 0.791 (p < 0.05), the
boundary value of 332 ng/l, sensitivity was 76.9%, speciﬁcity was
73.3%.
CONCLUSIONS Plasma BNP levels of AMI patients after 24 h
can predict MACE, help to understand LVRM earlier, to prevent or
slow down the occurrence and development of heart failure after
AMI.GW26-e1021
Study of serum ferritin levels in patients of Acute Coronary Syndrom
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OBJECTIVES To observe the level of SF in patients with
Acute Coronary Syndrome(ACS), and its relation with the severity
of coronary artery lesions, and explore the signiﬁcance of SF in
ACS.
METHODS Collect 126 patients with ACS, and 41 patients conﬁrmed
with cardiac neurosis as control group. The ACS group constituted
with 52 cases of patients with UA, 31 cases of patients with NSTEMI
and 43 cases of patients with STEMI. All patients took blood line for
routine blood, cTNI, CK-MB, BNP and other indicators. SF, lipid, renal
function, and biochemical examination undertook the next day on
